Your browser doesn't support javascript.
loading
Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposure.
Lebwohl, Mark G; Merola, Joseph F; Rowland, Katelyn; Miller, Megan; Yang, Ya-Wen; Yu, Jenny; You, Yin; Chan, Daphne; Thaçi, Diamant; Langley, Richard G.
Affiliation
  • Lebwohl MG; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Merola JF; Department of Dermatology and Department of Medicine, Division of Rheumatology and Immunology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
  • Rowland K; Janssen Scientific Affairs, LLC, Horsham, PA, USA.
  • Miller M; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Yang YW; Immunology Global Medical Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson, Horsham, PA, USA.
  • Yu J; Janssen Research & Development, LLC, Spring House, PA, USA.
  • You Y; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Chan D; Janssen Scientific Affairs, LLC, Horsham, PA, USA.
  • Thaçi D; Institute and Comprehensive Center for Inflammatory Medicine, University of Lübeck, Lübeck, Germany.
  • Langley RG; Division of Clinical Dermatology & Cutaneous Science, Dalhousie University, Halifax, NS, Canada.
Br J Dermatol ; 189(1): 42-52, 2023 07 07.
Article in En | MEDLINE | ID: mdl-37022762
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Br J Dermatol Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Br J Dermatol Year: 2023 Type: Article Affiliation country: United States